The GHIT Fund's malaria product development efforts were featured in The Asahi Shimbun (Morning Edition: Global Health Section) on August 20, 2026.

Martin Fitchett, CEO of Medicines for Malaria Venture (MMV)—a product development partner of the GHIT Fund—and Osamu Kunii, CEO of the GHIT Fund, were interviewed by The Asahi Shimbun. The article highlights the current state of malaria, ongoing research and development progress, and related initiatives.

Permission No. 26-1991

Published on this website with permission from The Asahi Shimbun Company.

Unauthorized reproduction or redistribution is strictly prohibited.

Online article (Subscription required and in Japanese only)

https://digital.asahi.com/articles/DA3S16529684.html